ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 5641 - 5655 of 5996 products
Shanghai Pharma Acquires Second API Maker This Year
$5.00
Available
Steve Yang: AstraZeneca in China Wants to Transform Pharma R&D Models
$5.00
Available
Cardinal Health Plans $90 Million in China Acquisitions
$5.00
Available
AstraZeneca Pairs 7,300 Job Cuts with China Spending
$5.00
Available
Tasly and SemBioSys Report Progress on their China JV
$5.00
Available
Frontage Labs Completes US Phase I Trial for China TCM Company
$5.00
Available
Beijing FDA Speeds Up its Fast-Track Review
$5.00
Available
Transgene Starts Two New China Ventures
$5.00
Available
Seven Young China Scientists Given $650,000 Howard Hughes Awards
$5.00
Available
Syneron Announces SFDA Approval for Five Aesthetic Machines
$5.00
Available
EntreMed Raises $10 Million from China-Connected Investors
$5.00
Available
Sanjiu Pharma to Bid up to $110 Million for Shunfeng Pharma
$5.00
Available
Jiangsu Kanion Out-licenses 3 Molecules to NewGen Therapeutics
$5.00
Available
ShangPharma Achieves First Milestone in Hengrui Biologics Partnership
$5.00
Available
Quintiles Opens New Support Center for China Clinical Trials
$5.00
Available